Nobel Biocare

Nobel Biocare is a global leader in the field of innovative dental implant and esthetic dentistry solutions. Founded in 1981, the company is renowned for pioneering the osseointegration concept in clinical practice, fundamentally transforming restorative dentistry. Headquartered in Zürich, Switzerland, it operates as a key business unit within Envista Holdings, offering a comprehensive portfolio of products and digital workflows for tooth replacement and aesthetic rehabilitation. Its technologies are utilized by dental professionals worldwide to improve patient outcomes in oral rehabilitation.

History

The company's origins are intrinsically linked to the pioneering work of Per-Ingvar Brånemark, a Swedish orthopedic surgeon who discovered the biological process of osseointegration in the 1950s. This discovery, demonstrating that titanium could fuse with living bone, laid the foundation for modern dental implantology. In 1981, entrepreneur Hans Geiselhöringer founded the company to commercialize Brånemark's research, initially under a license from the University of Gothenburg. A landmark event was the 1982 Toronto Conference, which presented long-term clinical data and established the Brånemark System as a scientifically validated treatment. The company expanded rapidly throughout the 1990s, introducing new implant designs and the revolutionary Procera system for CAD/CAM fabricated all-ceramic crowns. Significant corporate milestones include its acquisition by the Danaher Corporation in 2014 and its subsequent inclusion in the spin-off company, Envista Holdings, in 2019.

Products and Services

The company's portfolio encompasses a complete ecosystem for implant dentistry and digital dentistry. Its core offerings include a wide range of dental implant systems, such as the NobelParallel Conical Connection and NobelActive lines, designed for various bone densities and clinical situations. In prosthodontics, it provides abutments, surgical guides, and the NobelProcera system for manufacturing high-strength zirconia and lithium disilicate restorations. The NobelClinician software facilitates advanced treatment planning using cone beam computed tomography (CBCT) data, while the Nobel Biocare on Demand (NBD) platform connects clinics to its global production centers. Comprehensive solutions for full-arch rehabilitation, like the All-on-4 treatment concept, and products for soft tissue management round out its clinical offerings.

Research and Development

Innovation is driven by extensive collaboration with leading academic and clinical institutions worldwide, including the Brånemark Osseointegration Center and various University of Zurich departments. Its R&D efforts focus on enhancing implant surface technology to accelerate bone healing and improve primary stability, with surfaces like TiUnite and Xeal being key outcomes. Significant investment is directed toward advancing digital workflow integration, utilizing artificial intelligence in treatment planning and refining CAD/CAM processes for prosthetic fabrication. The company also conducts long-term clinical studies to validate new treatment protocols and materials, often presented at major congresses like the European Association for Osseointegration (EAO) and the American Academy of Implant Dentistry (AAID).

Corporate Affairs

As a subsidiary of Envista Holdings, a publicly traded company on the New York Stock Exchange (NYSE: NVST), it operates within a large medical technology enterprise. The global headquarters in Zürich oversees strategic direction, while major production and research facilities are located in Karlskoga, Sweden, and Yorba Linda, California. Its business model includes direct operations and a network of distributors serving over 80 countries. The company places a strong emphasis on professional education through the Nobel Biocare Global Symposium and partnerships with institutions like the International Congress of Oral Implantologists (ICOI) to train clinicians on its latest technologies and techniques.

Clinical Applications

The company's solutions are applied across a broad spectrum of restorative dentistry cases, from single-tooth replacement to complex edentulism. The All-on-4 treatment concept, developed with Paulo Maló, enables immediate fixed rehabilitation of the fully edentulous jaw using only four implants. For esthetic zone rehabilitations, its implants and prosthetic components are designed to support optimal gingival architecture and papilla preservation. Surgical protocols and guided surgery systems allow for minimally invasive flapless surgery, reducing patient recovery time. These applications are supported by a vast library of documented case studies and long-term data published in journals such as the International Journal of Oral & Maxillofacial Implants (IJOMI).

Category:Dental companies Category:Companies based in Zürich Category:Medical equipment companies of Switzerland